Brief: BioInvent Q2 Sales SEK 198.1 Million

BioInvent International AB

26/08/2025 07:30

Aug 26 (Reuters) - BioInvent Q2 adjusted free cash flow SEK 66.8 million.

Q2 adjusted EPS SEK -0.59

Q2 net income SEK -38.8 million